Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / FDMT - 4D Molecular Therapeutics new overweight at Barclays on genetic medicine platform

FDMT - 4D Molecular Therapeutics new overweight at Barclays on genetic medicine platform

4D Molecular Therapeutics Inc.

2024-04-15 12:22:22 ET

"We consider the cystic fibrosis and Fabry programs as free options and that validation of additional pipeline assets could provide long- term upside potential," she added. 4D-710, currently in phase 1/2, is the cystic fibrosis candidate, while 4D-310, also in phase 1/2, is the Fabry asset....

For further details see:

4D Molecular Therapeutics new overweight at Barclays on genetic medicine platform
Stock Information
Company Name: 4D Molecular Therapeutics Inc.
Stock Symbol: FDMT
Market: NASDAQ
Website: 4dmoleculartherapeutics.com
Menu
FDMT FDMT Quote FDMT Short FDMT News FDMT Articles FDMT Message Board
Get FDMT Alerts

News, Short Squeeze, Breakout and More Instantly...